Hidenobu Ishii Selected Research

Hidenobu Ishii Research Topics

Disease

25	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 12/2014
18	Neoplasms (Cancer) 10/2023 - 01/2014
9	Disease Progression 09/2023 - 09/2016
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 03/2015
5	Lung Neoplasms (Lung Cancer) 01/2019 - 09/2016
4	Adenocarcinoma 11/2021 - 01/2014
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
3	Adenocarcinoma of Lung 11/2021 - 10/2015
2	Diarrhea 01/2021 - 01/2020
2	Pneumonia (Pneumonitis) 01/2021 - 11/2018
2	Inflammation (Inflammations) 11/2018 - 11/2009
1	Adenoid Cystic Carcinoma (Cylindroma) 10/2023
1	Thymic epithelial tumor 03/2023
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Stomatitis 01/2020
1	Erythema Multiforme 01/2020
1	Anorexia 01/2020
1	Paronychia 01/2020
1	Infections 11/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2018
1	Febrile Neutropenia 11/2018
1	Dehydration (Water Stress) 11/2018
1	Fever (Fevers) 11/2018
1	Heart Failure 11/2018
1	Acute Kidney Injury (Acute Renal Failure) 11/2018
1	Myocarditis (Carditis) 11/2018
1	Neutropenia 11/2018
1	Respiratory Insufficiency (Respiratory Failure) 11/2018
1	Septic Shock (Toxic Shock Syndrome) 11/2018
1	Colitis 08/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2017
1	Pancytopenia 10/2017
1	Abdominal Pain (Pain, Abdominal) 10/2015
1	Ulcerative Colitis 10/2015
1	Gastrointestinal Hemorrhage (Hematochezia) 10/2015
1	Lymphoma (Lymphomas) 05/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2015
1	Asthma (Bronchial Asthma) 11/2009

Drug/Important Bio-Agent (IBA)

8	PlatinumIBA 01/2023 - 09/2016
6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2018
6	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2018
5	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 10/2015
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
4	AfatinibIBA 01/2023 - 01/2018
4	LigandsIBA 01/2023 - 03/2015
4	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 12/2018
4	Bevacizumab (Avastin)FDA Link 01/2021 - 10/2015
3	osimertinibIBA 01/2023 - 01/2020
3	Docetaxel (Taxotere)FDA Link 01/2021 - 11/2018
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 12/2014
3	Pemetrexed (MTA)FDA Link 06/2018 - 10/2015
2	durvalumabIBA 01/2023 - 01/2022
2	Monoclonal AntibodiesIBA 01/2023 - 10/2015
2	atezolizumabIBA 01/2023 - 01/2021
2	avelumabIBA 01/2021 - 11/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2019 - 05/2015
2	Cell-Free Nucleic AcidsIBA 01/2019 - 10/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 10/2015
1	Contrast MediaIBA 03/2023
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Amino Acids FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Extracellular Matrix ProteinsIBA 11/2021
1	PeriostinIBA 11/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Messenger RNA (mRNA)IBA 10/2019
1	Keratins (Keratin)IBA 05/2019
1	Carcinoembryonic AntigenIBA 05/2019
1	Tumor Biomarkers (Tumor Markers)IBA 05/2019
1	AntibodiesIBA 11/2018
1	Immune Checkpoint ProteinsIBA 11/2018
1	Lipase (Acid Lipase)FDA Link 11/2018
1	NivolumabIBA 08/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015
1	Caspase 3 (Caspase-3)IBA 10/2015
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2015
1	Anaplastic Lymphoma KinaseIBA 05/2015
1	GoldIBA 04/2015
1	Programmed Cell Death 1 ReceptorIBA 03/2015
1	Bronchodilator Agents (Bronchodilators)IBA 11/2009

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 10/2023 - 10/2015
8	Aftercare (After-Treatment) 01/2021 - 10/2015
6	Therapeutics 01/2022 - 11/2009
1	Proton Therapy 10/2023
1	Radiotherapy 01/2022
1	Adjuvant Chemotherapy 09/2017
1	Bronchoscopes 01/2017
1	Duration of Therapy 11/2016
1	Chemoradiotherapy 03/2016
1	Colectomy 10/2015
1	Pancreaticoduodenectomy 01/2014
1	Lymph Node Excision (Lymph Node Dissection) 01/2014